Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban in SwEden (OSCAR-SE)

NCT05150938 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05150938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05150938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Studies in Cancer Associated Thrombosis for Rivaroxaban in SwEden (OSCAR-SE)
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
March 18, 2022
Completion date
February 28, 2023
Enrollment
5,737 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment of venous thromboembolism in cancer patients